News

  • January 12, 2021
Verseon Receives European Patent for Innovative Thrombin Inhibitors
  • November 30, 2020
Trevor M. Jones Joins Verseon’s Scientific Advisory Board
  • September 30, 2020
Verseon Announces its Third Program Targeting Cancer
  • April 20, 2020
Verseon Publishes Efficacy Data on Anticoagulant VE-1902 in the Journal Thrombosis Research
  • February 24, 2020
Frank Doyle Joins Verseon’s Scientific Advisory Board
  • April 30, 2019
Verseon presents oral drug candidate for diabetic eye disease that could replace eye injections